Tim Watkins

CMO & Head of Development

CMO & Head of Development at Contineum Therapeutics, Inc., filing insider transactions on 2026-03-02.

Total Purchases

—

0 transactions

Total Sales

$54K

1 transaction

Companies Traded

1 total filings

Active Since

2026-03-02

Last: 2026-03-02

Companies

Contineum Therapeutics, Inc.

Date	Ticker	Type	Shares	Price	Value	Owned After
2026-03-02	CTNM	Sale	3,611	$15.02	$54K	0	SEC ↗